"Mind the Gap" in children's health insurance coverage: does the length of a child's coverage gap matter?

Jennifer E DeVoe1, Alan Graham, Lisa Krois

  • 1Department of Family Medicine, Oregon Health and Science University, Portland, Oregon 97239, USA. devoej@ohsu.edu

Insights

Gaps in children's health insurance coverage, even short ones, increase unmet medical needs. Longer gaps, especially over six months, significantly worsen access to care and health outcomes for low-income children.

Area of Science:

  • Health Services Research
  • Pediatric Health
  • Health Insurance Policy

Background:

  • Health insurance gaps can limit healthcare access for children.
  • The impact of the duration of these coverage gaps on health access is not well understood.

Purpose of the Study:

  • To investigate how different lengths of health insurance coverage gaps affect healthcare access for low-income children.
  • To identify specific health access outcomes associated with varying durations of insurance gaps.

Main Methods:

  • Cross-sectional analysis of statewide data from low-income families in Oregon.
  • Examined children presumed eligible for publicly funded health insurance.
  • Assessed six measures of healthcare access in relation to the length of insurance coverage gaps.

Main Results:

  • Over 25% of children experienced an insurance gap in the study year.
  • Any insurance gap increased the likelihood of unmet medical, dental, and prescription needs, lack of usual care, no doctor visits, and delayed urgent care.
  • Gaps exceeding six months were associated with worse outcomes than shorter gaps, and sometimes similar to or worse than never-insured children.

Conclusions:

  • Minimizing public health insurance gaps is crucial for ensuring continuous healthcare access for children.
  • State policies should aim to prevent or shorten insurance coverage gaps to improve pediatric health outcomes.
Abstract

Related Concept Videos

Introduction To Health Care Delivery System01:18

Introduction To Health Care Delivery System

The healthcare system is constantly changing and complex. Various services are available from different healthcare providers, but gaining access to these services has become challenging for people with limited healthcare insurance. Uninsured people present a challenge to healthcare because they frequently postpone or forego treatment.
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...